AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation

Research output: Contribution to journalArticlepeer-review


Colleges, School and Institutes


Smartphone applications (“apps”) with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers’ claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.

Bibliographic note

Not yet published as of 02/03/2021


Original languageEnglish
JournalBritish Journal of Cancer
Publication statusAccepted/In press - 14 Jan 2021